We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC

Delisted

LVAC was delisted on the 10th of May, 2023.

Back to rankings

54 hedge funds and large institutions have $116M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

12% more capital invested

Capital invested by funds: $104M → $116M (+$12.4M)

2% more funds holding

Funds holding: 53 → 54 (+1)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
12
Closed
7
Calls
$209K
Puts
–
Net Calls
+$209K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
QL
Quarry LP
New York
+$3.11M
2
UOC
UBS O'Connor
Illinois
+$2.94M
3
WCMNY
Westchester Capital Management (New York)
New York
+$2.38M
4
FTCM
First Trust Capital Management
Illinois
+$2.33M
5
PC
Periscope Capital
Ontario, Canada
+$2.08M

Top Sellers

Rank Fund Capital Flow
1
SC
Sculptor Capital
New York
-$4.39M
2
CCM
Context Capital Management
California
-$2.31M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$776K
4
SAMU
SONA Asset Management (US)
New York
-$611K
5
WAM
Weiss Asset Management
Massachusetts
-$514K
Name Holding Trade Value Shares
Change 		Change in
Stake
SCM
1
Saba Capital Management
New York
$11.2M – – –
PC
2
Periscope Capital
Ontario, Canada
$10.1M +$2.08M +201,031 +26%
SCM
3
Shaolin Capital Management
Florida
$9.28M +$1.96M +189,787 +27%
PAMP
4
Polar Asset Management Partners
Ontario, Canada
$7.8M – – –
CCA
5
Castle Creek Arbitrage
Colorado
$6.25M – – –
WCMNY
6
Westchester Capital Management (New York)
New York
$5.89M +$2.38M +229,812 +69%
GL
7
Governors Lane
New York
$5.11M – – –
Marshall Wace
8
Marshall Wace
United Kingdom
$4.44M – – –
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$3.13M -$776K -75,000 -20%
QL
10
Quarry LP
New York
$3.13M +$3.11M +300,000 New
Toronto Dominion Bank
11
Toronto Dominion Bank
Ontario, Canada
$3.13M – – –
UOC
12
UBS O'Connor
Illinois
$2.96M +$2.94M +283,573 New
CSS
13
Cubist Systematic Strategies
Connecticut
$2.66M -$379K -36,617 -13%
LA
14
Linden Advisors
New York
$2.61M – – –
TCM
15
Tenor Capital Management
New York
$2.61M – – –
FTCM
16
First Trust Capital Management
Illinois
$2.51M +$2.33M +225,000 +1,430%
WAM
17
Wolverine Asset Management
Illinois
$2.25M -$55.8K -5,391 -2%
WRBC
18
W.R. Berkley Corp
Connecticut
$2.17M – – –
AIMCA
19
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$2.09M – – –
D.E. Shaw & Co
20
D.E. Shaw & Co
New York
$2.09M – – –
RCM
21
Radcliffe Capital Management
Pennsylvania
$2.08M +$722K +69,762 +54%
FTCM
22
Fir Tree Capital Management
New York
$2.08M +$518K +50,000 +34%
CH
23
CVI Holdings
Delaware
$2.05M -$54.3K -5,242 -3%
Millennium Management
24
Millennium Management
New York
$1.62M – – –
AA
25
AQR Arbitrage
Connecticut
$1.56M -$19.6K -1,893 -1%
1
2 3

LVAC Hedge Fund Activity: Q1 2023 in Review

54 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q1 2023, worth a combined $116M — up 12% from $104M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new LVAC positions and 7 closed out — a net gain of 1 holder — while 7 added to existing stakes and 12 trimmed.

The largest buyer was Quarry LP, opening a new position worth an estimated $3.11M. The largest seller was Sculptor Capital, exiting entirely with an estimated $4.39M sold.

  • 54 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q1 2023, up from 53 in Q4 2022.
  • Funds reported $116M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q1 2023, up 12% quarter-over-quarter.
  • 8 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q1 2023 and 7 closed out, a net change of +1 holder.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q1 2023 was Quarry LP, an estimated $3.11M added.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q1 2023 was Sculptor Capital, an estimated $4.39M sold.

Based on aggregated 13F filings for Q1 2023.